Construction Boom Masks Lingering Cyclical Headwinds
Uniparts delivered a blowout Q1 with 27% revenue and 64% PAT growth, but reiterated full-year guidance implying only 23–24% growth. The call reveals why: margin elevation driven by warehouse sales mix is temporary, large ag remains at trough, and aftermarket weakness drags the year.
On the headline, Uniparts delivered a clean beat: ₹347.4 Cr revenue (+27% YoY) and ₹56.6 Cr PAT (+64% YoY), surpassing the company's own Q1 guidance. But the reiterated full-year guidance—'a couple percentage points better than FY26's 21%'—implies only 23–24% growth. That gap between the quarter and the year is the story.
Where the outperformance came from
The EBITDA margin of 25% sits 500 basis points above the company's 20% cycle target. Management is transparent: this elevation is not structural. It reflects two temporary tailwinds. First, warehouse sales jumped to 56% of revenue (from 50–52% prior), a channel mix shift driven by recovery-mode order fulfillment. Warehouse carries the highest margin; as the industry normalizes and direct exports and local sales grow, this mix reverts to the 50–52% range, compressing margins back toward cycle midline. Second, product mix shifted toward 3PL and PMP, which have lower material costs (33.3% in Q1 vs. 34–37% normal), yielding a small inventory gain (₹1 Cr) that management flagged as one-time. Strip both effects, and organic EBITDA margin is closer to 22–23%—solid but not peak.
The FY27 guidance gap explained
Why does management guide only 23–24% growth for the full year when Q1 is at 27%? Three material headwinds surface on the call. First, large agriculture is at a cyclical trough. Management expects a 15–16% decline in CY26 (after a 30% drop CY25), with recovery not arriving until FY28. This is the company's second-largest end-market and constrains H2 growth materially. Second, aftermarket demand remains under pressure. At 12% of Q1 revenue, aftermarket is flat in absolute terms but has shrunk from 20% (FY25) and 15% (FY26) as a mix percentage because OEM grew faster. Tariff-driven demand deferral is the culprit; management expects 12-month recovery but the timeline is not quantified. Third, construction momentum—while structural and expected to continue into FY28—is concentrated in the top 3 OEMs and must coexist with the ag trough to drive the full-year rate. Taken together, H2 growth likely trails H1, pulling the annual rate toward guidance.
What changed on this call
Construction segment upgraded to 45% of revenue; structural growth runway via top 3 OEM wins and new business order book ₹225 Cr
Aftermarket downgraded: now 12% (vs. 15% FY26, 20% FY25); tariff-driven deferral recovery timeline uncertain, extending headwind into FY28
Mexico warehouse commencing Q3 FY27; FY27 contribution mid-single-digit million $; Phase 2 local manufacturing under evaluation
Large ag share gains acknowledged; new wins from FY26 awards flowing revenue, but single-digit market share implies largest growth runway
Acquisition strategy unchanged: 6 targets under review, disciplined criteria (18–30 month ROCE/ROE payback), but zero progress (12 evaluated since IPO, zero closed)
Management claims vs. what holds up
Revenue growth 27% YoY, in line with guidance
Delivered ₹347.4 Cr (26.9% YoY), validates the claim
Supported
PAT growth 64% YoY; quality of execution
Delivered ₹56.6 Cr (64.3% YoY), strong absolute and leverage
Supported
Better than annual guidance despite challenges
Q1 at 27% beats guidance (~23–24%), but guidance framed conservously despite strong start
Slightly overstated
Margin expansion sustainable at 20%+ EBITDA
Q1 at 25% is cycle-high, driven by warehouse mix (56%) and product mix—both temporary tailwinds
Mixed
Small inventory gain ~₹1 Cr this quarter
Confirmed in Q&A; material cost 33.3% (vs. 34–37% normal) due to product mix shift
Supported
Bull-bear ledger
Construction momentum is structural. Top 3 global construction OEMs are customers; AI/smart manufacturing and European infrastructure are multi-year tailwinds. Segment at 45% with new wins flowing; expected to grow faster than ag into FY28.
Robust order book and new business pipeline. Trailing 12m order book ₹225 Cr provides 12+ month revenue visibility across geographies and segments. Reduces execution risk.
Balance sheet fortress. ₹190 Cr net cash rebuilt in 10 months post-special dividend. Capex at 2.5–3.5% of revenue leaves headroom for organic growth and M&A. Debt-free.
Reported profit leans on temporary margin tailwinds. EBITDA at 25% (vs. 20% cycle target) driven by warehouse mix 56% (vs. normal 50–52%) and product mix gains. As industry recovers, mix normalizes, margins compress.
Large agriculture trough timing uncertain. Largest near-term headwind. Management expects recovery FY28, but if macro worsens (US recession, farm stress), trough extends and full-year growth stays compressed.
Aftermarket weakness masks OEM growth. At 12% of revenue (vs. 20% FY25), aftermarket is flat in absolute terms but shrinking as a mix. Tariff-driven deferral recovery timeline vague. If recovery delays, revenue drag extends into FY28.
Acquisition execution track record weak. 12 targets evaluated since IPO; 6 under review; zero deals closed. ₹190 Cr net cash risks underdeployment if M&A doesn't materialize. Signals either capital discipline or missed inorganic runway.
Cyclical business; recovery timing is not given. Construction recovery is visible and structural. But large ag trough and aftermarket recovery both depend on macro (US capex, farm economics, tariff environment). Management flagged headwinds but not quantified recovery pace.
How the street is positioned
The market confirmed the beat but not yet extended conviction. On day 1 post-result, the stock popped +9.37% (delivered on 42.9% volume), holding most of the gain through day 3 (+11.14%) and consolidating at day 5 (+9.99%). Now at ₹806.2, the stock is 3.91% below its all-time high of ₹839 and trading 101.65% above its 52-week low (₹399.8). The relative strength index (RSI) stands at 73.2—overbought territory—signaling that near-term momentum may consolidate or pull back. Volume trend is increasing, a constructive sign, but not yet a break-out confirmation.
Institutional ownership has shifted modestly bullish. Foreign institutional investors (FII) added 56 basis points quarter-on-quarter to 3.38% (from 2.82% Q4 FY26), supporting the cycle recovery narrative and capital discipline. Domestic institutions (DII) have trimmed by 40 basis points to 4.94% (from 5.34%), likely profit-taking after the rally. Promoter holding remains stable at 65.88%. The FII inflow—while modest at absolute 3.38%—is a vote of confidence in the construction recovery thesis and balance sheet fortress, whereas the DII trim suggests some local profit-taking rather than conviction-ending distribution.
This price action aligns with the fundamental read: the market priced in the Q1 beat and confirmed the construction recovery story, but is cautiously positioned given the FY27 guidance implying deceleration to 23–24% growth and the overbought technical setup. No major distribution near the high; FII accumulation suggests institutions see cycle recovery as multi-quarter. However, the RSI overbought and the DII trim signal that a near-term consolidation or modest pullback is plausible before the next catalyst.
The debate
Risks, ranked by holder concern
Large ag recovery timing uncertain; trough extends if macro weakens
HighLargest near-term headwind. Management expects recovery FY28, but dependent on US capex and farm economics. If recession or farm stress persists, trough extends into FY28, constraining full-year growth and delaying margin recovery.
Customer concentration; top 5 ag OEMs and top 3 construction OEMs are primary customers
HighConcentrated OEM base means customer capex pullback or market-share loss impacts revenue disproportionately. Diversification limited to same global OEM base.
Aftermarket recovery timeline vague; demand deferral may not normalize in 12 months
MediumAftermarket at 12% revenue, flat YoY but shrinking as %. Tariff-driven deferral is culprit; tariffs reduced, but recovery timeline not quantified. If recovery delays, revenue drag extends into FY28.
Acquisition execution risk; zero deals closed despite ₹190 Cr cash and 12 targets evaluated
MediumM&A capital inefficiency is evident. Disciplined criteria (18–30 month ROCE/ROE) reduce overpay risk but also mean capital underdeployed. If M&A doesn't close, ₹190 Cr returned via dividends instead of high-ROIC acquisitions.
Warehouse sales mix normalization; 56% is temporary, compresses margins on recovery
MediumEBITDA at 25% propped by warehouse 56% (vs. normal 50–52%). As industry recovers, direct exports and local sales grow, warehouse % normalizes, margins compress to 20%. Timing and pace of compression uncertain.
Mexico warehouse ramp risk; Q3 FY27 execution and Phase 2 manufacturing commitment
LowMexico FY27 expected mid-single-digit million $. Early-stage; if customer production shift delays or warehouse demand lower, ramp slower. Phase 2 local manufacturing not yet funded; decision deferred until Phase 1 proven.
What to watch next
1 · Q2 organic momentum and guidance
Does construction sustain Q1-level growth? How does aftermarket trend? Management guided Q2 'in line with Q1' (25–27% revenue). Any miss signals macro pressure or customer caution. Adjusted margin (ex warehouse mix effect) is the key metric—anything below 22% would signal margin compression ahead of cycle normalization.
2 · Large ag recovery signals (CY27–FY28)
When does order flow improve from large ag OEMs? Recovery expected FY28, but early signs in H2 FY27 would de-risk the narrative. Management should provide CY26 actual decline data and CY27 early visibility. Slip in recovery timeline extends FY27 headwinds into FY28.
3 · Acquisition announcement or material update
6 targets under review; any closure (even a miss or restart) clarifies capital deployment intent. Continued silence raises concerns about M&A discipline masking capital inefficiency. A deal would signal confidence in inorganic runway (PTO, hydraulics, fabrication) and ROIC visibility.
4 · Mexico warehouse Phase 1 ramp and Phase 2 manufacturing decision
Q3 FY27 first customer deliveries are the prove-out. Any delays or demand miss signals execution risk or slower customer production shifts. Phase 2 manufacturing commitment (local Mexico mfg) by FY28 will unlock next-leg upside.
5 · Aftermarket demand recovery tangibility
Expected 12-month recovery from tariff-driven deferral. By Q3–Q4 FY27, does aftermarket volume show acceleration? If still flat or declining, recovery slips. Return to 15%+ of revenue mix would be the proof-point.
The honest read
Uniparts delivered a clean Q1 beat: 27% revenue growth, 64% PAT growth, EBITDA at 25%. The numbers are solid. But they are cycle-high numbers, propped by temporary mix effects (warehouse sales 56%, product mix), and the company's cautious full-year guidance (23–24% growth) signals management knows the headwinds are real: large ag at trough, aftermarket weakness, normal-season margin compression. This is not a step-change quarter; it is a good execution quarter in a cyclical recovery.
The construction recovery is real and structural—top 3 global OEM relationships are sticky, new business order book ₹225 Cr is visible, AI/smart manufacturing and infrastructure tailwinds are multi-quarter. But that recovery must coexist with an ag trough and aftermarket softness for the full year. H2 growth will likely decelerate from H1, pulling FY27 into management's guidance (23–24%). Management has been transparent on this tension; investors should respect it.
The stock is overbought (RSI 73.2) at ₹806.2, 4% below its all-time high. The day-1–day-5 rally (+9.37% to +11.14% held) shows market conviction in the cycle recovery, but no extended break-out yet. FII inflow (+56 bp to 3.38%) is a positive vote; DII trim (−40 bp) suggests some profit-taking. Near-term consolidation or a modest pullback is plausible on technicals; the fundamental story is intact for the cycle.
The number to track from here: organic earnings per the business cycle (next 18–24 months), not the margin peaks driven by warehouse mix. If large ag recovery timing slips, or if aftermarket recovery exceeds 12 months, full-year guidance will miss and cycle upside fades. Holders should monitor Q2 momentum and large ag recovery signals closely. New buyers should wait for consolidation and entry on weakness (₹750–₹770 would be more attractive on technicals).
Construction momentum drives beat; ag recovery ahead but uncertain timing
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Met Q1 guidance, beat margins (25% vs 20% cycle target). Acquisition track record weak (evaluated 12 targets, closed zero). Aftermarket headwind flagged but recovery timeline vague (12 months expected).
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong Q1 delivery (27% revenue, 64% PAT) driven by construction recovery and warehouse sales channel mix. But full-year guidance remains measured (~23-24% growth), ag recovery timetable uncertain, and persistent acquisition delays limit visibility. Balance sheet robust (₹190 Cr net cash, 2.5-3.5% capex ratio) supports medium-term growth, but cyclical exposure and aftermarket softness create near-term headwinds.
₹347 Cr
Revenue · +27% YoY₹57 Cr
Reported PAT · +64% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Revenue growth 27% YoY, in line with guidance
METDelivered 347.4 Cr (27% vs 346 Cr prior year), validates claim
PAT growth 64% YoY, quality of execution
METDelivered 56.6 Cr PAT (64% vs 34.4 Cr prior), supports claim
Better than annual guidance despite challenges
OVERSTATEDPrior guidance was FY26-level growth (21%); Q1 at 27% is ahead, but full-year guidance still cautious at 'couple percentage points better'
Margin expansion sustainable at 20%+ EBITDA
MixedQ1 at 25% EBITDA but management notes cycle average is 20%, elevation driven by warehouse sales mix (56%, up from 50-52% prior year)
Small inventory gain ~₹1 Cr this quarter
METConfirmed in Q&A, one-time benefit, material cost 33.3% due to product mix change
Earnings quality
What changed since the last call
Construction segment share increased to 45%
UpgradeConstruction grew faster than ag due to global AI/smart manufacturing (US) and infrastructure (Europe) tailwinds. New business wins structural; momentum expected to continue into FY28.
Aftermarket headwind persists longer
DowngradeAftermarket declined from 20% (FY25) to 15% (FY26) to 12% (Q1 FY27). Tariff-driven demand deferral expected to recover over 12 months, but timing more uncertain than prior quarter.
Mexico warehouse timeline confirmed
NewFirst customer deliveries expected Q3 FY27; FY27 revenue mid-single-digit million $. Phase 2 (local manufacturing) under consideration as customer production shifts to Mexico.
Large ag share gains acknowledged in new wins
UpgradeManagement confirmed new large ag business awards from FY26 now flowing revenue. Single-digit market share acknowledged, but validation/testing cycle (long) justifies growth strategy.
Acquisition strategy remains unchanged
Withdrawn6 targets currently under review; no new updates or timelines. Prior commitment to 'within 18-30 months ROCE/ROE payback' reiterated, but execution still elusive (evaluated 12 since IPO, closed zero).
The Q&A
Analysts pressed hard on acquisition delays (repeated), aftermarket recovery timeline, channel mix sustainability, and large ag market share strategy. Management held ground on disciplined M&A approach (value-accretion criteria, not rushing) and explained margin drivers (warehouse mix, product mix) clearly. Some defensive framing ('discipline', 'prudent') on M&A but transparent on rationale.
Construction segment growth — Ashutosh Tiwari, Equirus
AnsweredYes, structural drivers (new wins, industry recovery, wallet expansion) are multi-quarter. But ag recovery will rebalance mix; expected and healthy. Margins similar across products; channel (warehouse vs export vs local) is differentiator.
PTO and fabrication acquisitions — Saishivam Shah, Avendus Spark
PartialEvaluated ~12 targets since IPO; 6 under close review. Deal criteria: value-accretive within 18-30 months (ROCE/ROE), meaningful platform, manageable size, not distressed. No hurry; effort and intensity remain high; will update when concrete.
Margin drivers and sustainability — Viraj Kacharia, SiMPL
AnsweredSmall ₹1 Cr inventory gain. Material cost 33.3% due to product mix shift (3PL/PMP/fabrication have different material %). Channel: warehouse 56% (vs 50-52% prior), local-local 22% (vs ~25% prior), direct export ~22%. Warehouse margin highest; normal material range 34-37%.
Industry and FY27-FY28 growth — Sunil Jain, Nirmal Bang
AnsweredConstruction momentum continues FY27-FY28. Small ag growth starts CY27 (later this year). Large ag trough CY26 (mid-teens decline expected this year), recovery FY28. Cycle EBITDA margin 20% (peak-to-trough); current 23-25% but dependent on recovery pace, warehouse %, FX.
Large ag market share and CFM strategy — Anubhav Mukherjee, Prescient Capital
AnsweredLarge ag Western market; India is small ag country (50% global tractors). Validation/testing cycle slow; new wins flowing now (FY26 awards). CFM works with top 3 construction OEMs globally; order win book similar Europe/US; revenue will follow cycle. Efforts on new retailers in Europe/US underway.
Organic capital allocation and fabrication — Resham Jain, VVD Asset Managers
AnsweredInvested in fabrication facility 2.5 years ago while waiting for M&A; in discussions with OEM customers for fabrication supply. Capex 2.5-3.5% of revenue (organic + inorganic), fairly constant. Fabrication expected meaningful vertical in 18-24 months; still below capex headroom.
Multi-year guidance — Nishita Shanklesha, Sapphire Capital
PartialFY26 was +21%; FY27 will be couple percentage points better (~23-24%). Margins: cycle is 20%, current 24-25% in recovery mode. Expected above 20% going forward depending on recovery pace, warehouse %, FX. Capital is 2.5-3.5% organic; ₹190 Cr cash for M&A if needed.
Mexico facility and H2 guidance — Saumil Shah, Paras Investments
AnsweredMexico: export from India + warehouse model; Phase 2 local mfg under consideration. FY27 revenue mid-single-digit million $. Warehouse sales will remain 52-56% range (Mexico adds warehouse, but industry recovery adds direct/local sales). H2 better than H1 due to ag industry recovery in H2.
Quarterly momentum — Saumil Shah, Paras Investments (follow-up)
AnsweredQ2 looks very robust; should be in line with Q1.
Gross margin sustainability — Viraj Kacharia, SiMPL (follow-up)
AnsweredProduct mix (3PL/PMP/fabrication material % different) and channel mix (warehouse higher) drive elevation. Material cost should stay 34-37% (normal range); confident of 20% EBITDA over cycle. Variables stack differently at different cycle points.
Aftermarket recovery — Anubhav Mukherjee, Prescient Capital (follow-up)
PartialDemand deferral (tariffs, inflation, West Asia); not degrowth. Aftermarket flat YoY absolute but lower % (OEM grew faster). Tariffs reduced; expect normalization over 12 months. Note: aftermarket 20% FY25, 15% FY26, 12% Q1 FY27 (it gave anchor when OEM down). Adding new retail channels in US/Europe ongoing.
Aerospace/defense/China+ opportunity — Ashish Pareek, Individual Investor
AnsweredOff-highway supplier focused. TAM: below 70 HP 3PL (dominant), above 70 HP 3PL (single-digit, biggest runway), PMP (wallet expansion with top 3 construction OEMs), fabrication/hydraulics/PTOs (M&A targets). Construction customers in AI/smart manufacturing and mining (indirect exposure). Growth via wallet expansion, not sector pivot.
Cycle position and noncyclical growth — V.P. Rajesh, Banyan Capital
AnsweredConstruction recovering (started H2 CY25, continuing FY27-28). Small ag recovery just starting (CY27 main). Large ag at trough CY26 (down 30% CY25, down 15-16% CY26). New business wins split ag/construction, focused on large ag + construction (higher runways). Noncyclical growth via wallet expansion with top customers.
Channel mix detail — Ajit Sethi, Eiko Quantum Solutions
AnsweredQ1 FY27: warehouse 56%, local-local 22%, direct export 22%. Q1 FY26: warehouse 50-52%, local-local ~25%, direct export remainder.
Warehouse sales from Mexico — Sunil Jain, Nirmal Bang (follow-up)
AnsweredMexico warehouse increases warehouse %, but industry recovery also increases direct exports and local sales. Expect warehouse sales to stay in 52-56% range over 12-18 months (not structurally higher).
Guidance
FY27 growth couple percentage points better than FY26's 21%
MediumCouple = 2-3 percentage points, implies 23-24% FY27 growth. Conservative framing given Q1's 27%, but reflects caution on H2 ag recovery timing and full-year mix.
FY28 growth to continue as ag recovery kicks in
MediumLarge ag recovery expected FY28; small ag growth CY27 onwards. New business order book ₹225 Cr provides visibility; but timing of ag recovery still uncertain.
EBITDA margins above 20% delivered FY27; current at 24-25%
HighCycle average 20% (peak-to-trough); current elevation due to recovery mode, warehouse sales mix (56%), and operating leverage. Material cost range 34-37% normal; management confident maintaining 20%+ over cycle.
Warehouse sales range 52-56% going forward
MediumMexico warehouse will add warehouse sales, but industry recovery adds direct exports and local sales; mix expected to settle 52-56% over 12-18 months (not structurally higher than now).
Capex 2.5-3.5% of revenue (organic + maintenance)
HighQ1 capex ₹12 Cr (~3.5% of revenue). Capex ratio remains fairly constant; covers capacity, productivity, customer-led growth. Inorganic capex (M&A) to come from cash balance (₹190 Cr), debt-free.
Risks the call surfaced
Cyclical industry exposure
HighLarge ag in Western markets at trough CY26 (down 15-16% expected); can downturn extend if US recession or farm debt stress persists? Small ag Western recovery fragile after 3 years decline.
Customer concentration
HighTop 5 ag global OEMs and top 3 construction OEMs are primary customers; concentration risk if any customer loses market share or reduces capex in downturn; new business diversification limited to same OEM base.
Aftermarket headwind
MediumAftermarket (3PL replacement parts) 12% of revenue, flat YoY absolute but down from 15% FY26 and 20% FY25 due to tariff-driven price volatility and demand deferral. If recovery delays, revenue drag extends.
Acquisition execution risk
MediumEvaluated 12 M&A targets since IPO; 6 currently under review; zero deals closed. PTO/hydraulics/fabrication acquisitions promised for years but not materialized. If M&A doesn't close, ₹190 Cr cash underdeployed; organic capex 2.5-3.5% won't fully utilize balance sheet.
Mexico warehouse execution
LowMexico warehouse commencing Q3 FY27; FY27 revenue expected mid-single-digit million $ (~$3-8M). Phase 2 local manufacturing not yet committed. If customer production shift delays or warehouse demand lower than expected, revenue ramp slower.
Management
Score 8/10. Clear, structured, detailed (segments, geographies, cycle position explained). Provides specific numbers and ranges (channel mix 52-56%, capex 2.5-3.5%, order book ₹225 Cr). Transparent on aftermarket headwind and acquisition delays without excessive defensiveness. Met Q1 guidance and beat annual guidance; margin targets (20%+) being delivered (Q1 at 25%). New business wins in large ag and construction visible. Ludhiana facility disruption navigated without customer impact. Acquisition track record weak (12 evaluated, zero closed); persistent miss on timelines despite repeated reiteration.
1 · Q2 FY27
Management guided Q2 'in line with Q1', robust construction momentum likely to continue
2 · Q3 FY27
Mexico warehouse operations commence; mid-single-digit million $ revenue contribution expected to ramp
3 · FY28
Large ag industry recovery expected; new business wins from FY26 awards to flow revenue; second growth lever
Balance sheet robust (₹190 Cr net cash, 2.5-3.5% capex ratio) supports medium-term growth, but cyclical exposure and aftermarket softness create near-term headwinds.
Uniparts India Q1 FY27: consol PAT jumps 64% YoY to ₹56.6 Cr as margins expand, revenue +27%
PAT +64.25% YoY · revenue +26.95% · margins expanding
₹347.38 Cr
+26.95% YoY
₹56.61 Cr
+64.25% YoY
15.94%
+3.6pp YoY
₹12.54
Uniparts India's consolidated Q1 FY27 (quarter ended June 30, 2026) revenue came in at ₹347.4 Cr, up 26.95% YoY and 2.49% QoQ, while consolidated PAT rose 64.25% YoY and 10.68% QoQ to ₹56.6 Cr — basic EPS of ₹12.54 versus ₹7.64 a year ago and ₹11.33 last quarter. The print carries no exceptional items on either side of the comparison, so the growth is clean/unadjusted. Net profit margin expanded to 16.30% from 12.59% in Q1 FY26 (and 15.09% in Q4 FY26), while operating margin came in at 23.60% — up sharply from 19.11% a year ago, though marginally below Q4's 23.85%, indicating the margin gain is being sustained rather than a one-quarter spike. Standalone (India-only) revenue grew a slower 18.49% YoY to ₹191.6 Cr with PAT up 57.26% YoY to ₹23.0 Cr; the wider gap versus consolidated growth (27% revenue, 64% PAT) points to the US/international subsidiaries (Uniparts USA, Uniparts Olsen, Uniparts India GmbH) growing faster than the domestic entity this quarter.
Q1 FY-2027 vs prior quarters
On guidance, management's Q4 FY26 call had flagged Q1 FY27 to come in "in line with Q4" sequentially and reiterated a >20% EBITDA/operating-margin target for the year; the quarter met both — QoQ revenue was roughly flat (+2.49%) as guided, while operating margin at 23.60% stayed comfortably above the 20% threshold, and QoQ PAT growth (+10.68%) came in ahead of a flat sequential read. No formal analyst consensus estimates for this specific quarter could be found via web search, so vsStreet is unresolved; no separate management press release commentary was available beyond the regulatory filing and auditor's review reports. Alongside the results, the Board approved a first interim dividend of ₹9/share (90% of face value) aggregating ₹40.65 Cr, with a record date of August 12, 2026 — a continuation of shareholder returns rather than a signal tied to this quarter's numbers specifically. Management had previously flagged H2 FY27 as stronger than H1, so this quarter's steady-to-improving trajectory sets up a base to watch against that expectation.
The stock went into the print at ₹732.95, up 12.9% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; PAT has now risen for 2 consecutive quarters.
Uniparts India anticipates FY27 growth to be in line with FY26 performance, driven by a recovering industry cycle, execution of new business awards, and gradual end-market recovery. The company expects to operate comfortably above a 20% EBITDA margin, with the exact outcome dependent on revenue ramp-up and delivery cha
— This quarter: beat
W1
Management guided H2 FY27 stronger than H1 — confirm whether Q2 shows the ramp beyond this quarter's steady QoQ growth
W2
Operating margin sustainability above the guided >20% level — Q1 at 23.60% is just below Q4's 23.85%, watch for plateau vs continued expansion
W3
Pace of overseas subsidiary contribution (Uniparts USA/Olsen/GmbH) given consolidated growth (27% YoY) is outpacing standalone (18.5% YoY)
Both statements unaudited (limited review only), figures reported in ₹ Millions and converted to ₹ Crore (÷10). No exceptional items in this quarter or the year-ago quarter (blank rows) — no adjusted-YoY calc needed. EPS not annualised. Consolidated growth outpaces standalone, implying stronger overseas-subsidiary performance.